Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 28.07.2026, 17:09:35
335,40 DKK
Kurs
Kurs
2,73%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
450,00 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 335,40 290 | 335,40 | 290 | 13,536076 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 335,40 332 | 335,40 | 332 | 1,013715 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 335,40 285 | 335,40 | 285 | 15,026834 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 335,40 290 | 335,40 | 290 | 13,536076 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 335,40 325 | 335,40 | 325 | 3,100775 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 335,40 290 | 335,40 | 290 | 13,536076 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 335,40 305 | 335,40 | 305 | 9,063804 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 335,40 290 | 335,40 | 290 | 13,536076 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 335,40 290 | 335,40 | 290 | 13,536076 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 335,40 300 | 335,40 | 300 | 10,554562 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 335,40 175 | 335,40 | 175 | 47,823494 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 335,40 290 | 335,40 | 290 | 13,536076 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 335,40 290 | 335,40 | 290 | 13,536076 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 335,40 | 335,40 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 335,40 300 | 335,40 | 300 | 10,554562 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 335,40 332 | 335,40 | 332 | 1,013715 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 335,40 263 | 335,40 | 263 | 21,586166 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 335,40 175 | 335,40 | 175 | 47,823494 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 335,40 300 | 335,40 | 300 | 10,554562 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 335,40 275 | 335,40 | 275 | 18,008348 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 335,40 332 | 335,40 | 332 | 1,013715 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 335,40 263 | 335,40 | 263 | 21,586166 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 335,40 275 | 335,40 | 275 | 18,008348 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 335,40 300 | 335,40 | 300 | 10,554562 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 335,40 260 | 335,40 | 260 | 22,48062 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 335,40 400 | 335,40 | 400 | 19,260584 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 335,40 400 | 335,40 | 400 | 19,260584 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 335,40 332 | 335,40 | 332 | 1,013715 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 335,40 340 | 335,40 | 340 | 1,371497 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 335,40 275 | 335,40 | 275 | 18,008348 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 335,40 340 | 335,40 | 340 | 1,371497 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 335,40 275 | 335,40 | 275 | 18,008348 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 335,40 250 | 335,40 | 250 | 25,462135 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 335,40 340 | 335,40 | 340 | 1,371497 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 335,40 340 | 335,40 | 340 | 1,371497 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 335,40 340 | 335,40 | 340 | 1,371497 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 335,40 340 | 335,40 | 340 | 1,371497 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 335,40 400 | 335,40 | 400 | 19,260584 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 335,40 275 | 335,40 | 275 | 18,008348 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 335,40 360 | 335,40 | 360 | 7,334526 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 335,40 360 | 335,40 | 360 | 7,334526 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 335,40 360 | 335,40 | 360 | 7,334526 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 335,40 332 | 335,40 | 332 | 1,013715 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 335,40 475 | 335,40 | 475 | 41,621944 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 335,40 332 | 335,40 | 332 | 1,013715 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 335,40 360 | 335,40 | 360 | 7,334526 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 335,40 390 | 335,40 | 390 | 16,27907 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 335,40 436 | 335,40 | 436 | 29,994037 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 335,40 415 | 335,40 | 415 | 23,732856 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 335,40 360 | 335,40 | 360 | 7,334526 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 335,40 270 | 335,40 | 270 | 19,499106 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 335,40 390 | 335,40 | 390 | 16,27907 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 335,40 390 | 335,40 | 390 | 16,27907 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 335,40 360 | 335,40 | 360 | 7,334526 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 335,40 415 | 335,40 | 415 | 23,732856 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 335,40 475 | 335,40 | 475 | 41,621944 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 335,40 390 | 335,40 | 390 | 16,27907 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 335,40 400 | 335,40 | 400 | 19,260584 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 335,40 400 | 335,40 | 400 | 19,260584 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 335,40 360 | 335,40 | 360 | 7,334526 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 335,40 475 | 335,40 | 475 | 41,621944 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 335,40 475 | 335,40 | 475 | 41,621944 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 335,40 295 | 335,40 | 295 | 12,045319 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 335,40 295 | 335,40 | 295 | 12,045319 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 335,40 350 | 335,40 | 350 | 4,353011 | JPMORGAN |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M